Reticulocyte Hemoglobin helps monitor acute changes in hemoglobin incorporation into the erythron, which is measured at the cellular level. This provides a sensitive tool for the early detection of iron deficiency by the physician.

Utilizing Sysmex RET-He to Evaluate Anemia in Cancer Patients -
A Cancer Center Testimonial

Who Knew There Was So Much to Know about Retics?
WATCH WEBINAR >

Utility of RET-He in management of CKD Patients
READ PROFILE >

Reticulocyte Hemoglobin Content (RET-He): A Parameter withWell-Established
Clinical Value - to Learn About the Utility of RET-He
READ ARTICLE >

Utility of RET-He by Sysmex Clinical Support – for a brief overview of theclinical
utility of RET-He
WATCH VIDEO >

Acute Anemia Toolkit: Bloodless Strategies to Optimize Patient Outcomes
WATCH WEBINAR >

Utilizing Sysmex RET-He to Evaluate Anemia in Cancer Patients for an Examination of the Use of RET-He by Physicians in the Diagnosis of Anemia in a Cancer Patient Population
WATCH WEBINAR >

Use of Reticulocyte Hemoglobin in Anemia Assessment
WATCH WEBINAR >

Immature Granulocyte enumeration may aid in infection/inflammation surveillance
programs when used in conjunction with other clinical data.

IG - Biochemical and Hematological Markers of Inflammation Accurately Predict Sepsis and its Severity in ICU patients
READ ARTICLE >

IG - MLO Special Feature: Efficiency with IG May Reduce Smear Review Rate
READ ARTICLE >

IG - Immature Granulocytes as a Sepsis Predictor in Cardiac Patients
READ ABSTRACT >

IG - Sepsis Bibliography
READ ABSTRACTS >

IG - The New Business Model for Expanded Hematology Parameters � Immature Granulocyte
READ ARTICLE >

CAP Today March 2017: Q&A Column on Use of IG in Infection Management
READ ARTICLE >

Immature Granulocyte (IG) Populations May Improve the Assessment of Infection and Sepsis.
READ ARTICLE >

Read "Ban the Bands" to Learn Why an Automated IG Count is Better Than
Counting Bands
READ ARTICLE >

Utility of IG by Sysmex Clinical Support – for a Brief Overview of the Clinical
Utility of Immature Granulocyte
WATCH VIDEO >

Immature Platelet Fraction, a direct cellular indicator of thrombopoietic activity that
may aid physicians in assessing and monitoring thrombocytopenias.

Getting more from the CBC: IPF and Other Innovative CBC Parameters -
A Cancer Center Testimonial

The Role of the Immature Platelet Fraction (IPF) in the Differential Diagnosis of Thrombocytopenia
READ PROFILE >

Utility of IPF by Sysmex Clinical Support Team for a Brief Overview of theClinical Utility of IPF
WATCH VIDEO >

Challenges in the Evaluation of Thrombocytopenia in Newborns to Learn About the Clinical Significance, and Management of Thrombocytopenia inNeonates
WATCH WEBINAR >

CAP Today January 2018: Clin Lab 2.0- Add Value, Make Patients Better
READ ARTICLE >

CAP Today September 2017: Advanced Parameters Offer Faster, Surer Guidance to Cancer Care
READ ARTICLE >

ACP Introduction for a Brief Introduction to Sysmex’s Advanced Clinical Parameters by the Clinical Support Team
WATCH VIDEO >

Crazy Kids: A Look at the Challenges of Pediatric Hematology Through Case Study
WATCH WEBINAR >

Case Studies Demonstrating the Clinical Application of the Advanced Clinical Parameters
WATCH WEBINAR >

A Clinical Overview and Discussion of Laboratory Medicine in an Oncology Practice
WATCH WEBINAR >

Engaging Physicians on New Hematologic Parameters via Scientific Marketing to Learn How to Make Hematology Data Relevant for Your Patient Population
READ ARTICLE >

Want to learn more about ACPs? Visit our YouTube channel